Yang G - Search Results

1

Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.

Yang G, Stapleton AM, Wheeler TM, Truong LD, Timme TL, Scardino PT, Thompson TC. Yang G, et al. Clin Cancer Res. 1996 Feb;2(2):399-401. Clin Cancer Res. 1996. PMID: 9816183

2

Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC. Shimura S, et al. Among authors: yang g. Cancer Res. 2000 Oct 15;60(20):5857-61. Cancer Res. 2000. PMID: 11059783

3

Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD, Thompson TC. Tahir SA, et al. Among authors: yang g. Cancer Res. 2001 May 15;61(10):3882-5. Cancer Res. 2001. PMID: 11358800

4

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.

Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, Ren C, Wang J, Tahir SA, Thompson TC. Li L, et al. Among authors: yang g. Cancer Res. 2001 Jun 1;61(11):4386-92. Cancer Res. 2001. PMID: 11389065

5

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression.

Shaker MR, Yang G, Timme TL, Park SH, Kadmon D, Ren C, Ji X, Lee HM, Sehgal I, Anzano M, Sporn MB, Thompson TC. Shaker MR, et al. Among authors: yang g. Clin Exp Metastasis. 2000;18(5):429-38. doi: 10.1023/a:1010905309570. Clin Exp Metastasis. 2000. PMID: 11467776

6

In situ gene therapy for prostate cancer: immunomodulatory approaches.

Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Among authors: yang g. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.

7

In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.

Pramudji C, Shimura S, Ebara S, Yang G, Wang J, Ren C, Yuan Y, Tahir SA, Timme TL, Thompson TC. Pramudji C, et al. Among authors: yang g. Clin Cancer Res. 2001 Dec;7(12):4272-9. Clin Cancer Res. 2001. PMID: 11751529

8

The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.

Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, Thompson TC. Aihara M, et al. Among authors: yang g. Cancer. 1995 Jan 15;75(2):522-9. doi: 10.1002/1097-0142(19950115)75:2<522::aid-cncr2820750215>3.0.co;2-w. Cancer. 1995. PMID: 7529128

9

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Among authors: yang g. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

10

In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.

Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, Connell-Crowley L, Elledge SJ, Zhang WW, Harper JW, et al. Eastham JA, et al. Among authors: yang g. Cancer Res. 1995 Nov 15;55(22):5151-5. Cancer Res. 1995. PMID: 7585563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,500 results

Search Page

Filters